ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

Animesh D. Pardanani, Terra L. Lasho, Christy Finke, Darci L. Zblewski, Ramy A. Abdelrahman, Emnet A. Wassie, Naseema Gangat, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi

Research output: Contribution to journalLetter

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)534-536
Number of pages3
JournalBritish journal of haematology
Volume175
Issue number3
DOIs
StatePublished - Nov 1 2016

ASJC Scopus subject areas

  • Hematology

Cite this

Pardanani, A. D., Lasho, T. L., Finke, C., Zblewski, D. L., Abdelrahman, R. A., Wassie, E. A., Gangat, N., Hanson, C. A., Ketterling, R. P., & Tefferi, A. (2016). ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis. British journal of haematology, 175(3), 534-536. https://doi.org/10.1111/bjh.13865